<DOC>
	<DOCNO>NCT01603836</DOCNO>
	<brief_summary>The use autologous mesenchymal stem cell ( MSCs ) form BMC combination allograft effective option enhance Posterolateral Fusion ( PLF ) healing . Allograft effective material posterior onlay graft PLF adult surgery .</brief_summary>
	<brief_title>Study Confirms Refutes Hypothesis That Autologous Bone Marrow Concentrate Together With Allograft Better Alternative Posterolateral Fusion Spine Surgery Than Allograft Alone</brief_title>
	<detailed_description>The study prospective , randomize , control blind . Eighty patient degenerative disease lumbar spine underwent instrument lumbar lumbosacral PLF . In forty case , PLF do spongious allograft chip alone ( Group I ) . In another forty case , spongious allograft chip mixed BMC ( Group II ) , mesenchymal stem cell ( MSCs ) concentration 1.74 x104/L average ( range , 1.06-1.98 x104/L ) . Patients schedule anteroposterior lateral radiograph 12 24 month surgery CT scan 24 month surgery . Fusion status degree mineralization fusion mass evaluate separately two radiologist blind patient group affiliation .</detailed_description>
	<mesh_term>Spondylosis</mesh_term>
	<mesh_term>Spondylarthropathies</mesh_term>
	<criteria>degenerative disc disease degenerative spondylolisthesis vertebral fracture , infection spinal neoplasm , nonrigid instrumentation , medication affect bone mineralization ( e.g. , corticosteroid ) , body mass index high 35 , systemic disease , blood disease and/or immunosuppressant treatment and/or dicoumarol therapy ; immunosuppressant and/or neoplastic and/or infectious disease .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Lumbar spine</keyword>
	<keyword>Posterolateral fusion</keyword>
	<keyword>Allograft</keyword>
	<keyword>Bone marrow concentrate</keyword>
	<keyword>Mesenchymal stem cell</keyword>
	<keyword>Fusion rate</keyword>
</DOC>